Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Indevus In-Licenses Nebido To Complement Sanctura

Aug. 1, 2005

By Jennifer Boggs

Cerovive NDA Delayed: More Patients Needed For Phase III

July 29, 2005

By Jennifer Boggs

Cerovive NDA Delayed: More Patients Needed For Phase III

July 29, 2005

By Jennifer Boggs

Changes to delay EPIX trial of blood clot imaging agent

July 28, 2005

By Jennifer Boggs

Biogen Idec: Strong Sales Boost Earnings, Tysabri Data Looming

July 28, 2005

By Jennifer Boggs

Biogen Idec: Strong Sales Boost Earnings, Tysabri Data Looming

July 28, 2005

By Jennifer Boggs

Valeant Prepares For Phase III Retigabine Studies In Epilepsy

July 27, 2005

By Jennifer Boggs

Valeant Prepares For Phase III Retigabine Studies In Epilepsy

July 27, 2005

By Jennifer Boggs

Novacea Gains Rights To Oral Vinorelbine From Pierre Fabre

July 26, 2005

By Jennifer Boggs

Novacea Gains Rights To Oral Vinorelbine From Pierre Fabre

July 26, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...